This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Pregabalin Augmentation to Sertraline-Risperidone Combination in the Treatment of Obsessive-Compulsive Disorder

Panagotis Oulis, M.D.; Vasilios G. Masdrakis, M.D.; Nikolaos A. Karakatsanis, M.D.; Anastasios V. Kouzoupis, M.D.; George Konstantakopoulos, M.D.; Constantin R. Soldatos, M.D.

Published: June 16, 2008

Article Abstract
Pregabalin Augmentation to Sertraline-Risperidone Combination in the Treatment of Obsessive-Compulsive Disorder

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 10

Quick Links: Depression (MDD)

References

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...